Xiaoduo Fan to Schizophrenia
This is a "connection" page, showing publications Xiaoduo Fan has written about Schizophrenia.
Connection Strength
5.369
-
Fattahi C, Hamada K, Chiang M, Kosuru S, Polavarapu M, Sitthichai R, Fan X. A narrative review of mindfulness-based therapy for schizophrenia, co-occurring substance use and comorbid cardiometabolic problems. Psychiatry Res. 2021 02; 296:113707.
Score: 0.611
-
Oh SJ, Fan X. Current understanding on the role of nitric oxide and therapeutic potential of NO supplementation in schizophrenia. Schizophr Res. 2020 08; 222:23-30.
Score: 0.586
-
Oh SJ, Fan X. The Possible Role of the Angiotensin System in the Pathophysiology of Schizophrenia: Implications for Pharmacotherapy. CNS Drugs. 2019 06; 33(6):539-547.
Score: 0.547
-
Chiang M, Reid-Varley WB, Fan X. Creative art therapy for mental illness. Psychiatry Res. 2019 05; 275:129-136.
Score: 0.539
-
Fan X, Copeland P, Nawras S, Harrington A, Freudenreich O, Goff DC, Henderson DC. Adjunctive telmisartan treatment on body metabolism in clozapine or olanzapine treated patients with schizophrenia: a randomized, double blind, placebo controlled trial. Psychopharmacology (Berl). 2019 Jun; 236(6):1949-1957.
Score: 0.536
-
Mitra S, Natarajan R, Ziedonis D, Fan X. Antioxidant and anti-inflammatory nutrient status, supplementation, and mechanisms in patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2017 08 01; 78:1-11.
Score: 0.474
-
Chiang M, Natarajan R, Fan X. Vitamin D in schizophrenia: a clinical review. Evid Based Ment Health. 2016 Feb; 19(1):6-9.
Score: 0.433
-
Rajan S, Zalpuri I, Harrington A, Cimpeanu C, Song X, Fan X. Relationship between serum uric acid level and cardiometabolic risks in nondiabetic patients with schizophrenia. Int Clin Psychopharmacol. 2016 Jan; 31(1):51-6.
Score: 0.432
-
Fan X, Liu E, Freudenreich O, Copeland P, Hayden D, Ghebremichael M, Cohen B, Ongur D, Goff DC, Henderson DC. No effect of adjunctive, repeated-dose intranasal insulin treatment on psychopathology and cognition in patients with schizophrenia. J Clin Psychopharmacol. 2013 Apr; 33(2):226-30.
Score: 0.357
-
Fan X, Borba CP, Copeland P, Hayden D, Freudenreich O, Goff DC, Henderson DC. Metabolic effects of adjunctive aripiprazole in clozapine-treated patients with schizophrenia. Acta Psychiatr Scand. 2013 Mar; 127(3):217-26.
Score: 0.343
-
Chiang M, Lombardi D, Du J, Makrum U, Sitthichai R, Harrington A, Shukair N, Zhao M, Fan X. Methamphetamine-associated psychosis: Clinical presentation, biological basis, and treatment options. Hum Psychopharmacol. 2019 09; 34(5):e2710.
Score: 0.139
-
Song X, Fan X, Li X, Kennedy D, Pang L, Quan M, Chen X, Gao J, Zhang W, Zhang J, Lv L. Serum levels of BDNF, folate and homocysteine: in relation to hippocampal volume and psychopathology in drug na?ve, first episode schizophrenia. Schizophr Res. 2014 Oct; 159(1):51-5.
Score: 0.098
-
Song X, Li X, Gao J, Zhao J, Li Y, Fan X, Lv L. APOA-I: a possible novel biomarker for metabolic side effects in first episode schizophrenia. PLoS One. 2014; 9(4):e93902.
Score: 0.096
-
Song X, Fan X, Song X, Zhang J, Zhang W, Li X, Gao J, Harrington A, Ziedonis D, Lv L. Elevated levels of adiponectin and other cytokines in drug na?ve, first episode schizophrenia patients with normal weight. Schizophr Res. 2013 Oct; 150(1):269-73.
Score: 0.092
-
Li J, Li X, Liu E, Copeland P, Freudenreich O, Goff DC, Henderson DC, Song X, Fan X. No effect of adjunctive, repeated dose intranasal insulin treatment on body metabolism in patients with schizophrenia. Schizophr Res. 2013 May; 146(1-3):40-5.
Score: 0.089